Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $6,546 | 23 | 55.1% |
| Food and Beverage | $5,185 | 225 | 43.7% |
| Education | $100.65 | 5 | 0.8% |
| Debt forgiveness | $43.67 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ethicon Inc. | $3,827 | 28 | $0 (2022) |
| Boston Scientific Corporation | $2,005 | 10 | $0 (2018) |
| Veran Medical Technologies, Inc. | $1,555 | 9 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $796.88 | 34 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $558.95 | 34 | $0 (2023) |
| Medical Device Business Services, Inc. | $481.48 | 6 | $0 (2022) |
| GlaxoSmithKline, LLC. | $442.56 | 32 | $0 (2023) |
| Philips Electronics North America Corporation | $363.38 | 8 | $0 (2019) |
| Grifols USA, LLC | $276.44 | 26 | $0 (2021) |
| Intuitive Surgical, Inc. | $164.59 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $262.55 | 7 | AstraZeneca Pharmaceuticals LP ($98.94) |
| 2022 | $3,934 | 40 | Ethicon Inc. ($2,903) |
| 2021 | $1,191 | 29 | Ethicon Inc. ($877.63) |
| 2020 | $620.23 | 22 | Veran Medical Technologies, Inc. ($230.20) |
| 2019 | $2,295 | 69 | Veran Medical Technologies, Inc. ($1,274) |
| 2018 | $1,916 | 50 | Boston Scientific Corporation ($984.81) |
| 2017 | $1,656 | 37 | BOSTON SCIENTIFIC CORPORATION ($1,020) |
All Payment Transactions
254 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: RESPIRATORY | ||||||
| 05/02/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $92.84 | General |
| Category: SURGERY | ||||||
| 05/01/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: ONCOLOGY | ||||||
| 04/03/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $85.60 | General |
| Category: Oncology | ||||||
| 02/15/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Oncology | ||||||
| 02/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug), OFEV, OFEV | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: RESPIRATORY | ||||||
| 02/06/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Immunology | ||||||
| 12/19/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug), OFEV | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2022 | Medical Device Business Services, Inc. | — | Food and Beverage | In-kind items and services | $30.10 | General |
| 12/09/2022 | Medical Device Business Services, Inc. | — | Food and Beverage | In-kind items and services | $22.58 | General |
| 12/09/2022 | Medical Device Business Services, Inc. | — | Food and Beverage | In-kind items and services | $9.68 | General |
| 12/08/2022 | Medical Device Business Services, Inc. | — | Travel and Lodging | In-kind items and services | $265.59 | General |
| 12/08/2022 | Medical Device Business Services, Inc. | — | Travel and Lodging | In-kind items and services | $26.53 | General |
| 11/02/2022 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $95.73 | General |
| Category: Oncology | ||||||
| 10/24/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Respiratory | ||||||
| 10/19/2022 | Inogen, Inc. | InogenOne (Device) | Food and Beverage | Cash or cash equivalent | $13.33 | General |
| Category: Oxygen Concentrator | ||||||
| 10/11/2022 | Teva Pharmaceuticals USA, Inc. | AirDuo Digihaler (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Respiratory | ||||||
| 09/07/2022 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: PAH | ||||||
| 09/06/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: RESPIRATORY | ||||||
| 08/24/2022 | Teva Pharmaceuticals USA, Inc. | AirDuo Digihaler (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Respiratory | ||||||
| 08/23/2022 | Teva Pharmaceuticals USA, Inc. | AirDuo Digihaler (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Respiratory | ||||||
| 08/11/2022 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $114.11 | General |
| Category: Endo-Mechanical | ||||||
| 08/02/2022 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Oncology | ||||||
| 07/28/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: RESPIRATORY | ||||||
| 07/22/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 644 | 795 | $244,406 | $66,003 |
| 2022 | 16 | 611 | 793 | $231,446 | $70,482 |
| 2021 | 16 | 1,065 | 1,364 | $454,021 | $123,434 |
| 2020 | 26 | 1,651 | 2,326 | $898,522 | $196,539 |
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 132 | 187 | $28,611 | $12,801 | 44.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 76 | 76 | $33,668 | $12,318 | 36.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 125 | $28,125 | $12,082 | 43.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 42 | 48 | $20,880 | $6,810 | 32.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 75 | $11,475 | $4,856 | 42.3% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 69 | 77 | $50,230 | $4,647 | 9.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $7,518 | $2,137 | 28.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 19 | $4,180 | $1,780 | 42.6% |
| 31629 | Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | Facility | 2023 | 13 | 13 | $9,061 | $1,542 | 17.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 32 | 32 | $5,504 | $1,450 | 26.3% |
| 31652 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | Facility | 2023 | 11 | 11 | $8,811 | $1,274 | 14.5% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 30 | 30 | $4,080 | $1,049 | 25.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 32 | 32 | $6,336 | $990.72 | 15.6% |
| 31645 | Aspiration of initial secretion of lung airway using an endoscope | Facility | 2023 | 22 | 22 | $12,166 | $854.62 | 7.0% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2023 | 12 | 12 | $4,116 | $773.37 | 18.8% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 15 | 15 | $9,645 | $638.10 | 6.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 140 | $31,718 | $13,912 | 43.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 68 | 73 | $31,755 | $11,891 | 37.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 67 | 67 | $29,681 | $11,833 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 95 | 153 | $23,480 | $10,516 | 44.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 46 | 78 | $11,934 | $4,454 | 37.3% |
| 71250 | Ct scan of chest without contrast | Office | 2022 | 55 | 64 | $41,806 | $4,049 | 9.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 17 | $5,441 | $2,402 | 44.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 28 | $6,160 | $2,359 | 38.3% |
| 31629 | Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | Facility | 2022 | 16 | 16 | $11,152 | $1,879 | 16.9% |
About Dr. Michael Layton, MD
Dr. Michael Layton, MD is a Pulmonary Disease healthcare provider based in Sebastian, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255430096.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Layton, MD has received a total of $11,876 in payments from pharmaceutical and medical device companies, with $262.55 received in 2023. These payments were reported across 254 transactions from 33 companies. The most common payment nature is "Travel and Lodging" ($6,546).
As a Medicare-enrolled provider, Layton has provided services to 3,971 Medicare beneficiaries, totaling 5,278 services with total Medicare billing of $456,458. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease, Pulmonary Disease
- Location Sebastian, FL
- Active Since 09/21/2006
- Last Updated 10/10/2012
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1255430096
Products in Payments
- Monarch Platform (Device) $3,954
- Spin (Device) $1,555
- ALAIR (Device) $1,008
- ULTRAFLEX (Device) $749.74
- OFEV (Drug) $364.68
- SYMBICORT (Drug) $262.25
- GENERAL PULMONARY (Device) $235.07
- Prolastin-C Liquid (Biological) $230.44
- Respiratoriy Care Undiv (Device) $203.71
- DUPIXENT (Biological) $200.99
- IMFINZI (Biological) $185.63
- STIOLTO RESPIMAT (Drug) $180.38
- Da Vinci Surgical System (Device) $164.59
- TRELEGY ELLIPTA (Drug) $163.14
- TAGRISSO (Drug) $147.06
- ANORO (Drug) $127.71
- Wellcentive Undiv (Device) $126.10
- BEVESPI AEROSPHERE (Drug) $117.57
- BREO (Drug) $95.69
- Pulmonx Endobronchial Valve EBV (Device) $91.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.